Nanexa
0.96 SEK +2.35%3 investors are following this company
Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NANEXA
Daily low / high price
0.94 / 0.97
SEK
Market cap
130.27M SEK
Turnover
70K SEK
Volume
74K
Financial calendar
Interim report
2024-08-27
Interim report
2024-11-07
Annual report
2025-02-19
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Novo Nordisk A/S | 19.9 % | 19.9 % |
Avanza Pension | 5.7 % | 5.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Nanexa appoints new Chief Financial Officer
Första patient doserad i Nanexas fas I-studie med NEX-22 inom typ 2-diabetes
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools